Literature DB >> 11153540

Molecular genetics of schizophrenia.

B J Mowry1, D J Nancarrow.   

Abstract

1. Schizophrenia is a chronic, disabling brain disease that affects approximately 1% of the world's population. It is characterized by delusions, hallucinations and formal thought disorder, together with a decline in socio-occupational functioning. While the causes for schizophrenia remain unknown, evidence from family, twin and adoption studies clearly demonstrates that it aggregates in families, with this clustering largely attributable to genetic rather than cultural or environmental factors. Identifying the genes involved, however, has proven to be a difficult task because schizophrenia is a complex trait characterized by an imprecise phenotype, the existence of phenocopies and the presence of low disease penetrance. 2. The current working hypothesis for schizophrenia causation is that multiple genes of small to moderate effect confer compounding risk through interactions with each other and with non-genetic risk factors. The same genes may be commonly involved in conferring risk across populations or they may vary in number and strength between different populations. To search for evidence of such genetic loci, both candidate gene and genome-wide linkage studies have been used in clinical cohorts collected from a variety of populations. Collectively, these works provide some evidence for the involvement of a number of specific genes (e.g. the 5-hydroxytryptamine (5-HT) type 2a receptor (5-HT2a) gene and the dopamine D3 receptor gene) and as yet unidentified factors localized to specific chromosomal regions, including 6p, 6q, 8p, 13q and 22q. These data provide suggestive, but no conclusive, evidence for causative genes. 3. To enable further progress there is a need to: (i) collect fine-grained clinical datasets while searching the schizophrenia phenotype for subgroups or dimensions that may provide a more direct route to causative genes; and (ii) integrate recent refinements in molecular genetic technology, including modern composite marker maps, DNA expression assays and relevant animal models, while using the latest analytical techniques to extract maximum information in order to help distinguish a true result from a false-positive finding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11153540     DOI: 10.1046/j.1440-1681.2001.03399.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  10 in total

1.  PKNOX2 is associated with formal thought disorder in schizophrenia: a meta-analysis of two genome-wide association studies.

Authors:  Ke-Sheng Wang; Qunyuan Zhang; Xuefeng Liu; Longyang Wu; Min Zeng
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

Review 2.  Trace amine-associated receptors and their ligands.

Authors:  R Zucchi; G Chiellini; T S Scanlan; D K Grandy
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

Review 3.  Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?

Authors:  Hans H Schiffer
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

4.  Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia.

Authors:  Ke-Sheng Wang; Lingjun Zuo; Daniel Owusu; Yue Pan; Xingguang Luo
Journal:  J Schizophr Res       Date:  2014-08-01

5.  Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands.

Authors:  Bruce I Turetsky; Tiffany A Greenwood; Ann Olincy; Allen D Radant; David L Braff; Kristin S Cadenhead; Dorcas J Dobie; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Gregory A Light; James Mintz; Keith H Nuechterlein; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Monica E Calkins
Journal:  Biol Psychiatry       Date:  2008-08-13       Impact factor: 13.382

Review 6.  Schizophrenia: solving the puzzle.

Authors:  B D Kelly; E O'Callaghan; A Lane; C Larkin
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

7.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

8.  Genetic factors for alcohol dependence and schizophrenia: common and rare variants.

Authors:  Kesheng Wang; Xingguang Luo; Lingjun Zuo
Journal:  Austin J Drug Abuse Addict       Date:  2014-05-05

9.  A Novel Microduplication in the Neurodevelopmental Gene SRGAP3 That Segregates with Psychotic Illness in the Family of a COS Proband.

Authors:  Nicole K A Wilson; Yohan Lee; Robert Long; Karen Hermetz; M Katharine Rudd; Rachel Miller; Judith L Rapoport; Anjené M Addington
Journal:  Case Rep Genet       Date:  2011-09-12

10.  The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis.

Authors:  Jianbo Yu; Xufeng Liao; Yanzi Zhong; Yongqiang Wu; Xinsheng Lai; Huifeng Jiao; Min Yan; Yu Zhang; Chaolin Ma; Shunqi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-08       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.